Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.
The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire ...
The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is ...
The changes reflect “a cultural shift” around obesity medications, said Diana Zuckerman, president of the nonprofit National ...
On second thought, the FDA figures it no longer needs to discuss Exelixis’ application for Cabometyx in neuroendocrine tumors ...
The FDA has granted priority review to a Biologics License Application for nipocalimab to treat individuals with generalized ...
Opponents argue that the change could cause current smokers to use more cigarettes to compensate for the lower nicotine ...
Years of research have showed that pulse oximeters yield less accurate readings for people with darker skin tones, and now ...
The FDA has set maximum levels for lead in baby food. A new California law requires baby food makers selling products in the ...
By Sneha S K and Sriparna Roy (Reuters) -The U.S. Food and Drug Administration said on Friday that it has approved an ...
The recalled "Connie's Thin Crust Cheese Pizza" was issued a Class II risk level by the FDA, the second-most severe risk ...
The FDA's draft recommendations for pulse oximeters aims to include clinical studies involving at least 150 participants with ...